Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study

Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study

Abstract This phase II study's aim was to confirm the efficacy and safety of hypofractionated carbon‐ion radiotherapy in patients with stage I peripheral nonsmall cell lung cancer (NSCLC). The study encompassed 37 patients with histologically proven peripheral stage I NSCLC in the period June 2...

Full description

Bibliographic Details
Main Authors: Jun‐ichi Saitoh, Katsuyuki Shirai, Tatsuji Mizukami, Takanori Abe, Takeshi Ebara, Tatsuya Ohno, Koichi Minato, Ryusei Saito, Masanobu Yamada, Takashi Nakano
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Cancer Medicine
Subjects:
carbon‐ion radiotherapy
heavy ion radiotherapy
nonsmall cell lung cancer
phase II clinical trial
prospective study
Online Access:https://doi.org/10.1002/cam4.2561

Similar Items

Similar Items